Buy & Sell Jayamas Medica Industri Tbk. - OMED Share Price Today
Quarterly
Yearly
Income Statement
Revenue
Net Profit
Net Loss
Profit margin %
Q4
’24
Q1
’25
Q2
’25
Q3
’25
Q4
’25
| Item | Q4 2025 | Y/Y Change |
| Revenue | Rp2.06T | +9.44% |
| Cost of Revenue | Rp1.35T | +6.69% |
| Gross Profit | Rp717.5B | +14.99% |
| General Expenses, Depreciation, Interest | Rp326.6B | +18.55% |
| Operating Profit | Rp390.9B | +12.17% |
| Other Income | Rp64.03B | +40.57% |
| EBT | Rp454.93B | +15.46% |
| Taxes | -Rp85.99B | +22.71% |
| Net Income | Rp366.95B | +14.07% |
Balance Sheet
Assets
Liabilities
Debt to Asset %
Q4
’24
Q1
’25
Q2
’25
Q3
’25
Q4
’25
| Item | Q4 2025 | Y/Y Change |
| Total Assets | Rp3.2T | +13.18% |
| Total Liabilities | Rp445.08B | +35.02% |
| Total Equity | Rp2.72T | +10.53% |
| Total Liabilities & Total Equity | Rp3.17T | +13.42% |
Cash Flow
Operating
Investing
Finance
Net CF
Q4
’24
Q1
’25
Q2
’25
Q3
’25
Q4
’25
| Item | Q4 2025 | Y/Y Change |
| CF from Operations | Rp395.08B | +12.38% |
| CF from Investment | Rp229.08B | +39.55% |
| CF from Financing | Rp95.4B | +0.21% |
| Net Cash Flow | Rp70.6B | -23.44% |